| Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells R Duhen, C Ballesteros-Merino, AK Frye, E Tran, V Rajamanickam, ... Nature communications 12 (1), 1-14, 2021 | 136 | 2021 |
| Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer AJ Gunderson, V Rajamanickam, C Bui, B Bernard, J Pucilowska, ... Oncoimmunology 10 (1), 1900635, 2021 | 124 | 2021 |
| Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers C Zheng, JN Fass, YP Shih, AJ Gunderson, NS Silva, H Huang, ... Cancer Cell 40 (4), 410-423. e7, 2022 | 90 | 2022 |
| Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor BD Curti, Y Koguchi, RS Leidner, AS Rolig, ER Sturgill, Z Sun, Y Wu, ... Journal for immunotherapy of cancer 9 (4), 2021 | 67 | 2021 |
| PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors R Duhen, O Fesneau, KA Samson, AK Frye, M Beymer, V Rajamanickam, ... The Journal of Clinical Investigation 132 (12), 2022 | 55 | 2022 |
| Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling DA Pedroza, V Rajamanickam, R Subramani, A Bencomo, A Galvez, ... British journal of cancer 123 (8), 1326-1335, 2020 | 53 | 2020 |
| Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk RG Waller, TM Darlington, X Wei, MJ Madsen, A Thomas, K Curtin, ... PLoS genetics 14 (2), e1007111, 2018 | 48 | 2018 |
| Genetic risk factors in two Utah pedigrees at high risk for suicide DG H Coon, T Darlington, R Pimentel, K R Smith, C D Huff, H Hu, L Jerominski ... Translational Psychiatry, 2013 | 45 | 2013 |
| A case series of metastatic metaplastic breast carcinoma treated with anti-PD-1 therapy I Kim, V Rajamanickam, B Bernard, B Chun, Z Sun, WL Redmond, ... Frontiers in Oncology 11, 635237, 2021 | 24 | 2021 |
| Uterine inflammatory myofibroblastic tumors: proposed risk stratification model using integrated clinicopathologic and molecular analysis NR Ladwig, GR Bean, M Pekmezci, J Boscardin, NM Joseph, N Therrien, ... The American journal of surgical pathology 47 (2), 157-171, 2023 | 16 | 2023 |
| Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer B Chun, J Pucilowska, SC Chang, I Kim, B Nikitin, Y Koguchi, ... Journal for immunotherapy of cancer 10 (1), 2022 | 15 | 2022 |
| Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genome-wide significant breast cancer locus at 12q15 MJ Madsen, S Knight, C Sweeney, R Factor, M Salama, IJ Stijleman, ... Cancer Epidemiology, Biomarkers & Prevention 27 (6), 644-652, 2018 | 15 | 2018 |
| A phase Ib study of preoperative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early-stage breast cancer DB Page, J Pucilowska, KG Sanchez, VK Conrad, AK Conlin, AK Acheson, ... Clinical Cancer Research 26 (7), 1595-1605, 2020 | 13 | 2020 |
| TBX2 drives neuroendocrine prostate cancer through exosome-mediated repression of miR-200c-3p GK Patel, S Dutta, M Mahmud Syed, S Ramachandran, M Sharma, ... Cancers 13 (19), 5020, 2021 | 12 | 2021 |
| Arginase therapy combines effectively with immune checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth MD Badeaux, AS Rolig, G Agnello, D Enzler, MJ Kasiewicz, L Priddy, ... Cancer Immunology Research 9 (4), 415-429, 2021 | 12 | 2021 |
| microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy SB Nandy, R Subramani, V Rajamanickam, R Lopez-Valdez, ... BMC cancer 14, 1-13, 2014 | 12 | 2014 |
| Robust antitumor immunity in a patient with metastatic colorectal cancer treated with cytotoxic regimens V Rajamanickam, C Ballesteros-Merino, K Samson, D Ross, B Bernard, ... Cancer Immunology Research 9 (6), 602-611, 2021 | 9 | 2021 |
| A breast tissue protein expression profile contributing to early parity-induced protection against breast cancer CM Gutierrez, R Lopez-Valdez, R Subramani, A Arumugam, S Nandy, ... Cellular Physiology and Biochemistry 37 (5), 1671-1685, 2015 | 9 | 2015 |
| Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites T Muijlwijk, DNLM Nijenhuis, SH Ganzevles, A Brink, C Ke, JN Fass, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | 8 | 2024 |
| Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer B Bernard, V Rajamanickam, C Dubay, B Piening, E Alonso, Z Jutric, ... PLoS One 15 (8), e0238380, 2020 | 8 | 2020 |
Arunkumar ArumugamAssociate Principal Scientist at CBMVerified email at cfbm.com